Skip to content

Evaluation of 4D Magnetic Resonance Flow Sequence at Hepatic Level

Evaluation of 4D Magnetic Resonance Flow Sequence at Hepatic Level

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02821078
Acronym
HEPAFLUX
Enrollment
44
Registered
2016-07-01
Start date
2017-03-16
Completion date
2019-01-24
Last updated
2025-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Magnetic Resonance Imaging

Keywords

phase-contrast MRI, blood flow, velocity mapping, abdominal imaging, Quantitative MRI

Brief summary

The objective of the project is to establish the 3D velocity mapping of the hepatic vasculature and its consistency

Detailed description

The objective of the project is to establish the 3D velocity mapping of the hepatic vasculature and its consistency. Specifically, the investigators will assess the consistency of the quantitative data by measuring hepatic blood Inflow (hepatic artery + portal vein) and outflow (inferior vena cava differential flow). According to the mass conservation physical property, blood inflow must equals blood outflow. The relative gap between the measured values will characterize the consistency of the acquisition.

Interventions

OTHER4D flow imaging sequence

4D flow imaging sequence

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants have fasted for 6 hours before examination * Adult participants

Exclusion criteria

* Anyone with a classic contraindication to MRI * Recanalized umbilical vein * Severe obesity * Gadolinium chelate allergy

Design outcomes

Primary

MeasureTime frameDescription
Hepatic blood flow differenceDay 0difference between (hepatic artery + portal vein flows) and inferior vena cava differential flow (infra and supra hepatic)

Secondary

MeasureTime frameDescription
Comparison between 4D and 2D flowDay 0Comparison between 4D and 2D flow values measured at the portal trunk level

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026